Safety of secukinumab treatment in COVID-19 affected psoriatic patients

Mugheddu, Cristina
First
Writing - Original Draft Preparation
;Sanna, Silvia
Member of the Collaboration Group
;Atzori, Laura
Penultimate
Writing - Review & Editing
;Rongioletti, Franco
Last
Supervision
2021-01-01
2021
2020
Inglese
DERMATOLOGIC THERAPY
34
1
e14710
WOS:000604133600001
2-s2.0-85099069632
33368887
Esperti anonimi
internazionale
scientifica
COVID-19; Psoriasis; Interstitial pneumonia; Secukinumab; Therapy
no
Mugheddu, Cristina; Sanna, Silvia; Atzori, Laura; Rongioletti, Franco
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
4
reserved
Files in This Item:
File Size Format  
secukinumab covid patients dth.14710.pdf

Solo gestori archivio

Type: versione post-print
Size 2.21 MB
Format Adobe PDF
& nbsp; View / Open   Request a copy
2.21 MB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie